Mosaic loss of chromosome Y is associated with common variation near TCL1A

Nature Genetics

Volumn 48, Issue 5, 2016, Pages 563-568

  Zhou, Weiyin ^a,b   Machiela, Mitchell J ^a   Freedman, Neal D ^a   Rothman, Nathaniel ^a   Malats, Nuria ^c   Dagnall, Casey ^a,b   Caporaso, Neil ^a   Teras, Lauren T ^d   Gaudet, Mia M ^d   Gapstur, Susan M ^d   Stevens, Victoria L ^d   Jacobs, Kevin B ^b,e   Sampson, Joshua ^a   Albanes, Demetrius ^a   Weinstein, Stephanie ^a   Virtamo, Jarmo ^f   Berndt, Sonja ^a   Hoover, Robert N ^a   Black, Amanda ^a   Silverman, Debra ^a   Figueroa, Jonine ^a   Garcia Closas, Montserrat ^a,g   Real, Francisco X ^c,h   Earl, Julie ^c   Marenne, Gaelle ^c   Rodriguez Santiago, Benjamin ^h,i,j   Karagas, Margaret ^k   Johnson, Alison ^l   Schwenn, Molly ^m   Wu, Xifeng ⁿ   Gu, Jian ⁿ   Ye, Yuanqing ⁿ   Hutchinson, Amy ^a,b   Tucker, Margaret ^a   Perez Jurado, Luis A ^h,i,o   Dean, Michael ^a,p   Yeager, Meredith ^a,b   Chanock, Stephen J ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c Centro Nacional de Investigations Oncológicas   (Spain)

^d AMERICAN CANCER SOCIETY   (United States)

^e BioInformed LLC   (United States)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h UNIVERSITAT POMPEU FABRA   (Spain)

ⁱ CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^j Quantitative Genomic Medicine Laboratories   (Spain)

^k DARTMOUTH MEDICAL SCHOOL   (United States)

^l Vermont Cancer Registry   (United States)

^m Maine Cancer Registry   (United States)

ⁿ UNIVERSITY OF TEXAS   (United States)

^o HOSPITAL DEL MAR   (Spain)

^p NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDES AND PROTEINS; T CELL LEUKEMIA LYMPHOMA 1A; UNCLASSIFIED DRUG; DNA; ONCOPROTEIN; TCL1A PROTEIN, HUMAN;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SURVIVAL; CHROMOSOME LOSS; CONTROLLED STUDY; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOSAIC LOSS OF CHROMOSOME Y; MOSAICISM; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; AGED; CHROMOSOME 14; CHROMOSOME DELETION; COHORT ANALYSIS; GENE FREQUENCY; GENETIC VARIATION; GENETICS; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; Y CHROMOSOME;

AGED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, Y; COHORT STUDIES; DNA, NEOPLASM; GENE FREQUENCY; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MOSAICISM; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 84963522549     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3545     Document Type: Article

References (35)

1. Pierre R.V, & Hoagland H.C. Age-Associated aneuploidy: loss of Y chromosome from human bone marrow cells with aging. Cancer. 30, 889-894 (1972).
2. United Kingdom Cancer Cytogenetics Group (UKCCG). Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosom. Cancer. 5, 83-88 (1992).
3. Guttenbach M, Koschorz B, Bernthaler U, Grimm T, & Schmid M. Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei. Am. J. Hum. Genet. 57, 1143-1150 (1995).
4. Jacobs P.A, Brunton M, Court Brown W.M, Doll R, & Goldstein H. Change of human chromosome count distribution with age: evidence for a sex differences. Nature. 197, 1080-1081 (1963).
5. Abeliovich D, Yehuda O, Ben-Neriah S, & Or R. Loss of Y chromosome. An age-related event or a cytogenetic marker of a malignant clone? Cancer Genet. Cytogenet. 76, 70-71 (1994).
6. Herens C, et al. Loss of the Y chromosome in bone marrow cells: results on 1907 consecutive cases of leukaemia and preleukaemia. Clin. Lab. Haematol. 21, 17-20 (1999).
7. Wiktor A, et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosom. Cancer. 27, 11-16 (2000).
8. Wong A.K, et al. Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/myelodysplastic syndrome? Arch. Pathol. Lab. Med. 132, 1329-1332 (2008).
9. Zhang L.J, Shin E.S, Yu Z.X, & Li S.B. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders. Chin. Med. J. (Engl.) 120, 2002-2005 (2007).
10. Chanock S. Cancer biology: genome-wide association studies. in World Cancer Report 2014 (eds. Stewart B, & Wild C.P.) 193-202 (International Agency for Research on Cancer, 2014).
11. Conrad D.F, et al. Origins and functional impact of copy number variation in the human genome. Nature. 464, 704-712 (2010).
12. González J.R, et al. A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data. BMC Bioinformatics. 12, 166 (2011).
13. Itsara A, et al. Population analysis of large copy number variants and hotspots of human genetic disease. Am. J. Hum. Genet. 84, 148-161 (2009).
14. Jacobs K.B, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nat. Genet. 44, 651-658 (2012).
15. Laurie C.C, et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat. Genet. 44, 642-650 (2012).
16. Machiela M.J, et al. Characterization of large structural genetic mosaicism in human autosomes. Am. J. Hum. Genet. 96, 487-497 (2015).
17. McCarroll S.A, & Altshuler D.M. Copy-number variation and association studies of human disease. Nat. Genet. 39 (suppl. 7), S37-S42 (2007).
18. Peiffer D.A, et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res. 16, 1136-1148 (2006).
19. Dumanski J.P, et al. Smoking is associated with mosaic loss of chromosome Y. Science. 347, 81-83 (2015).
20. Forsberg L.A, et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat. Genet. 46, 624-628 (2014).
21. Xie M, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472-1478 (2014).
22. Jaiswal S, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488-2498 (2014).
23. Genovese G, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477-2487 (2014).
24. Fernández L.C, Torres M, & Real F.X. Somatic mosaicism: on the road to cancer. Nat. Rev. Cancer. 16, 43-55 (2016).
25. Machiela M.J, & Chanock S.J. Detectable clonal mosaicism in the human genome. Semin. Hematol. 50, 348-359 (2013).
26. Skaletsky H, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 423, 825-837 (2003).
27. Laine J, Künstle G, Obata T, Sha M, & Noguchi M. The protooncogene TCL1 is an Akt kinase coactivator. Mol. Cell. 6, 395-407 (2000).
28. Virgilio L, et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc. Natl. Acad. Sci. USA. 95, 3885-3889 (1998).
29. Olcaydu D, et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat. Genet. 41, 450-454 (2009).
30. Olcaydu D, et al. The ?GGCC? haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia. 23, 1924-1926 (2009).
31. Jones A.V, et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat. Genet. 41, 446-449 (2009).
32. Kilpivaara O, et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms. Nat. Genet. 41, 455-459 (2009).
33. Machiela M.J, & Chanock S.J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 31, 3555-3557 (2015).
34. Rothman N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet. 42, 978-984 (2010).
35. Wu X, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet. 41, 991-995 (2009).